Human Mdm2: A new molecular link to late-stage metastatic breast cancer

Dec 02, 2009

A large proportion of late-stage breast cancers that have spread to other parts of the body (metastatic breast cancers) are characterized by overexpression of the protein Mdm2.

Lindsey Mayo and colleagues, at Indiana University School of Medicine, Indianapolis, have now determined what drives this increased Mdm2 expression and found that Mdm2 helps promote take on more aggressive characteristics, making it a potential target for drugs to treat late-stage metastatic breast cancer.

In the study, a signaling pathway triggered by the molecule TGF-beta-1 was found to increase Mdm2 expression in human cancer cell lines. Expression of activated molecules involved in this pathway correlated with Mdm2 expression in many late-stage breast cancer samples analyzed.

The increased level of Mdm2 in the human cancer cell lines led to decreased expression of the key . More importantly, it enabled the cells to gain the ability to move freely in vitro after exposure to TGF-beta-1 (a key feature of cells that cause metastatic tumors). As an antagonist of the effects of Mdm2 on p53 prevented TGF-beta-1 from enabling cells to move freely in culture, the authors suggest that targeting Mdm2 might help prevent progression of late-stage .

More information: TGF-β1-induced expression of human Mdm2 correlates with late-stage . View this article at: http://www.jci.org/articles/view/39194?key=EC7lQbgq0ivAliJkn5z3

Source: Journal of Clinical Investigation

Explore further: Anal, throat cancers on the rise among young adults, study finds

add to favorites email to friend print save as pdf

Related Stories

Study pinpoints protein's role in cancer spread

Jul 24, 2006

Edinburgh scientists have identified the way a specific cell protein can trigger the spread of cancer. The study by researchers in the Cell Signalling Unit, University of Edinburgh Cancer Research Centre could pave the way ...

Oncoproteins double-team and destroy vital tumor-suppressor

Feb 14, 2008

Two previously unconnected cancer-promoting proteins team up to ambush a critical tumor suppressor by evicting it from the cell's nucleus and then marking it for death by a protein-shredding mechanism, a team led by scientists ...

Recommended for you

Clearing cells to prevent cervical cancer

5 hours ago

A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after ...

Is Europe putting cancer research at risk?

8 hours ago

The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General Data Protection Regulation could make ...

User comments : 0